For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Atara Biotherapeutics Inc (NASDAQ: ATRA) closed at $0.56 up 5.00% from its previous closing price of $0.53. In other words, the price has increased by $5.00 from its previous closing price. On the day, 2.53 million shares were traded. ATRA stock price reached its highest trading level at $0.5637 during the session, while it also had its lowest trading level at $0.4843.
Ratios:
For a deeper understanding of Atara Biotherapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on November 09, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $31 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’24 when Touchon Pascal sold 24,844 shares for $0.72 per share. The transaction valued at 17,888 led to the insider holds 1,910,652 shares of the business.
Nguyen AnhCo sold 10,746 shares of ATRA for $7,737 on Mar 04 ’24. The EVP, Chief Sci. & Tech Officer now owns 941,397 shares after completing the transaction at $0.72 per share. On Mar 04 ’24, another insider, Murugan Amar, who serves as the EVP, Chief Legal Officer of the company, sold 10,044 shares for $0.72 each. As a result, the insider received 7,232 and left with 727,521 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATRA now has a Market Capitalization of 66999464 and an Enterprise Value of 76989536. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.93. Its current Enterprise Value per Revenue stands at 2.218 whereas that against EBITDA is -0.357.
Stock Price History:
Over the past 52 weeks, ATRA has reached a high of $2.54, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -19.13%, while the 200-Day Moving Average is calculated to be -44.86%.
Shares Statistics:
For the past three months, ATRA has traded an average of 1.68M shares per day and 1537450 over the past ten days. A total of 120.42M shares are outstanding, with a floating share count of 111.10M. Insiders hold about 7.74% of the company’s shares, while institutions hold 57.98% stake in the company. Shares short for ATRA as of 1714435200 were 11878883 with a Short Ratio of 7.06, compared to 1711584000 on 11227598. Therefore, it implies a Short% of Shares Outstanding of 11878883 and a Short% of Float of 10.01.
